10083
In rare cases mitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome , which is characterized by hemolytic anemia , thrombocytopenia and progressive renal failure .
 adverse effect: hemolytic anemia, mitomycin C; adverse effect: hemolytic anemia, MMC; adverse effect: hemolytic uremic syndrome, mitomycin C; adverse effect: hemolytic uremic syndrome, MMC; adverse effect: progressive renal failure, mitomycin C; adverse effect: progressive renal failure, MMC; adverse effect: thrombocytopenia, mitomycin C; adverse effect: thrombocytopenia, MMC
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  hemolytic anemia, mitomycin C; hemolytic anemia, MMC; hemolytic uremic syndrome, mitomycin C; hemolytic uremic syndrome, MMC; progressive renal failure, mitomycin C; progressive renal failure, MMC; thrombocytopenia, mitomycin C; thrombocytopenia, MMC 
Answer:
 adverse effect: hemolytic anemia, mitomycin C; adverse effect: hemolytic anemia, MMC; adverse effect: hemolytic uremic syndrome, mitomycin C; adverse effect: hemolytic uremic syndrome, MMC; adverse effect: progressive renal failure, mitomycin C; adverse effect: progressive renal failure, MMC; adverse effect: thrombocytopenia, mitomycin C; adverse effect: thrombocytopenia, MMC